| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 6.445 | 6.992 | 6.852 | 5.028 | 3.920 | 4.403 | 3.793 | 2.879 | 2.022 | 0 |
| Total Income - EUR | 6.445 | 6.992 | 6.852 | 5.028 | 3.920 | 4.403 | 3.793 | 2.879 | 2.022 | 0 |
| Total Expenses - EUR | 704 | 418 | 926 | 639 | 202 | 270 | 196 | 438 | 1.126 | 16.803 |
| Gross Profit/Loss - EUR | 5.742 | 6.574 | 5.926 | 4.390 | 3.717 | 4.133 | 3.597 | 2.441 | 896 | -16.803 |
| Net Profit/Loss - EUR | 5.476 | 6.364 | 5.720 | 4.239 | 3.579 | 3.999 | 3.484 | 2.385 | 755 | -16.803 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
Check the financial reports for the company - Acvamed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 5.836 | 6.567 | 5.892 | 10.001 | 9.615 | 4.129 | 3.596 | 2.507 | 3.254 | 1.819 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 35 | 223 | 13 | 706 | 42 | 414 | 0 | 426 | 284 | 1.782 |
| Cash | 5.802 | 6.344 | 5.878 | 9.295 | 9.573 | 3.716 | 3.596 | 2.081 | 2.971 | 37 |
| Shareholders Funds | 0 | 134 | 5.851 | 5.744 | 5.420 | 124 | 121 | 2.507 | 3.254 | -14.318 |
| Social Capital | 0 | 134 | 131 | 129 | 126 | 124 | 121 | 122 | 121 | 121 |
| Debts | 5.701 | 6.433 | 40 | 4.257 | 4.195 | 4.005 | 3.475 | 0 | 0 | 16.137 |
| Income in Advance | 135 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "322 - 322" | |||||||||
| CAEN Financial Year |
322
|
|||||||||
Comments - Acvamed S.r.l.